08 July 2021 : Clinical Research
Transurethral Microwave Thermotherapy (TUMT) in the Treatment of Benign Prostatic Hyperplasia: A Preliminary Report
Roger J. Ziętek1BDF, Zbigniew M. Ziętek
123ACE*
DOI: 10.12659/MSM.931597
Med Sci Monit 2021; 27:e931597
Table 3 Baseline International Index of Erectile Function-5 IIEF-5 scores and after 6 months of observations in the patients allocated in the transurethral microwave thermotherapy (TUMT) and pharmacologic (control) group. P, P1, P2, and P3 indicate statistical significance according to the Z test: P, baseline comparison between TUMT and control group; P1, 6-month follow-up comparison between the TUMT and control groups; P2, only within the TUMT group, baseline vs 6-month follow-up; P3, only within the control group, baseline vs 6-month follow-up.
| IIEF-5 scale symptoms | Before | After | ||||
|---|---|---|---|---|---|---|
| n (%) | P, P3 | n (%) | P1, P2 | |||
| TUMT | Control | TUMT | Control | |||
| No ED | 210 (25%) | 208 (20%) | <0.41 | 235 (28%) | 156 (15%) | <0.0001 |
| <0.0027 | <0.081 | |||||
| Mild | 258 (31%) | 356 (34%) | <0.71 | 334 (40%) | 375 (36%) | <0.0989 |
| <0.8726 | <0.0001 | |||||
| Mild to moderate | 196 (23%) | 267 (26%) | <0.84 | 186 (22%) | 292 (28%) | <0.0032 |
| <0.215 | <0.5619 | |||||
| Moderate | 106 (13%) | 148 (14%) | <0.95 | 35 (4%) | 148 (14%) | <0.0001 |
| =1.0 | <0.0001 | |||||
| Severe | 70 (8%) | 61 (6%) | <0.17 | 50 (6%) | 68 (7%) | <0.603 |
| <0.5221 | <0.03 | |||||
| Total | 840 (100%) | 1040 (100%) | 840 (100%) | 1040 (100%) | ||
| IIEF-5 – International Index of Erectile Function-5; ED – erectile dysfunction; TUMT – transurethral microwave thermotherapy. | ||||||